Thomas Schinecker

Thomas Schinecker

politician Switzerland

Thomas Schinecker is the CEO of Roche, a leading global healthcare company. He is also a member of the board of the Lucerne Festival, where he contributes to the strategic direction of this renowned cultural institution.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
35,552
Power
2,028$
Sentiment
6.91
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Switzerland 2 6.50 0.14% +0% 8,654,622 12,121 $700,000 980$
Canada 1 7.00 0.06% +0% 38,005,238 23,431 $1,700,000 1,048$
Totals 3 46,659,860 35,552 $2,400,000 2,028$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Canada Canada: Thomas Schinecker, chief executive officer of Roche Holding AG, told analysts that selling directly to consumers would be one of the easiest ways to impact pricing for the patient. 7

The Globe and Mail: Trump demands drug companies lower prices in U.S. and raise them in other countries

Switzerland Switzerland: Roche-CEO Thomas Schinecker expressed satisfaction with the operational results during the presentation of the half-year results. 7

Neue Zürcher Zeitung: viel Licht, aber auch Schatten

Switzerland Switzerland: Thomas Schinecker, the CEO of Roche, hinted that the company's targets could be exceeded by the end of the year. 6

Neue Zürcher Zeitung: Aus Sorge um Zölle lässt Roche den Ausblick lieber unverändert

Switzerland Switzerland: Thomas Schinecker, the CEO of Roche, noted that Switzerland is known for being expensive in many areas, but not for medications. 5

Neue Zürcher Zeitung: Schweiz soll höhere Preise für Medikamente bezahlen

Switzerland Switzerland: Thomas Schinecker, the CEO of Roche, explained that the upcoming events would not significantly affect Roche. 6

Neue Zürcher Zeitung: Spediteure wie Kühne + Nagel gewannen, jetzt wackelt der Welthandel

Canada Canada: Chief Executive Thomas Schinecker said the investment underscored Roche’s commitment to the United States. 7

The Globe and Mail: Roche to invest US$50-billion in U.S. to avoid Trump tariffs, create 12,000 jobs